BioSante Announces FDA Orphan Drug Designation for GVAX Pancreatic Cancer Vaccine – MarketWatch (press release)

BioSante Announces FDA Orphan Drug Designation for GVAX Pancreatic Cancer Vaccine MarketWatch (press release) BioSante is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. ... SmallCapReview - Small Cap Stocks to Watch - XOMA, BPAXTransWorldNews (press release) all 28 news articles »

You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed.